| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 09/26/2002 | CA2441510A1 Muteins of hypoxia inducible factor alpha and methods of use thereof |
| 09/26/2002 | CA2441275A1 Gene cluster for rabelomycin biosynthesis and its use to generate compounds for drug screening |
| 09/26/2002 | CA2441042A1 Monoclonal antibody therapy for pancreas cancer |
| 09/26/2002 | CA2440966A1 Characterization of the i-spomi endonuclease from fission yeast |
| 09/26/2002 | CA2440960A1 An early pre-symptomatic prion diagnostic blood test for encephalopathies |
| 09/26/2002 | CA2440747A1 Novel nucleic acids and polypeptides |
| 09/26/2002 | CA2440272A1 Nucleic acid-associated proteins |
| 09/26/2002 | CA2440028A1 Rearranged squamous cell carcinoma antigen genes ii |
| 09/26/2002 | CA2439916A1 Compositions and methods for the treatment and clinical remission of psoriasis |
| 09/26/2002 | CA2438483A1 Histidine phosphatase interacting protein with 240kd |
| 09/26/2002 | CA2438315A1 Attenuated pasteurellaceae bacteria and an anti-bacterial vaccine prepared therefrom |
| 09/26/2002 | CA2435664A1 Ncc2705-the genome of a bifidobacterium |
| 09/25/2002 | EP1243655A1 Modified HPV E6 and E7 genes and proteins useful for vaccination |
| 09/25/2002 | EP1243652A2 Glial derived neurotrophic factor |
| 09/25/2002 | EP1243650A2 Process for constructing a cdna library, and a polypeptide and dna coding for the same |
| 09/25/2002 | EP1243648A1 Novel guanosine triphosphate-binding protein-coupled receptors, genes thereof and production and uses thereof |
| 09/25/2002 | EP1243647A1 Modified alpha-1,2-fucosyltransferase gene and process for producing alpha-1,2-fucosyltransferase and fucose-containing sugar chain |
| 09/25/2002 | EP1243645A1 Penicillin production using transgenic merodiploid strains |
| 09/25/2002 | EP1243596A2 Catalytic domains of the human hepatocyte growth factor receptor tyrosine kinase and methods for identification of inhibitors thereof |
| 09/25/2002 | EP1243256A1 Vaccines absorbable by the transmucosal way |
| 09/25/2002 | EP1242629A2 Implication of a known gene named cp2/lsf-lbp-1 in alzheimer's desease |
| 09/25/2002 | EP1242624A2 Methods and compositions for identifying morphogenic protein analogs using morphogenic protein responsive inhibitory elements |
| 09/25/2002 | EP1242617A2 Method of classifying a thyroid carcinoma using differential gene expression |
| 09/25/2002 | EP1242612A1 Method for continuous cultivation of microorganisms of the genus eremothecium |
| 09/25/2002 | EP1242602A1 PROTEIN EXPRESSION SYSTEMS FOR NON-PATHOGENIC i KINETOPLASTIDAE /i |
| 09/25/2002 | EP1242601A1 Trichoderma reesei xylanase |
| 09/25/2002 | EP1242600A1 Cytokine zcyto18 |
| 09/25/2002 | EP1242599A2 Method for obtaining human cdc25 phosphatases and method for identifying human cdc25 phosphatase modulators |
| 09/25/2002 | EP1242596A1 Methods and materials relating to novel von willebrand/thrombospondin-like polypeptides and polynucleotides |
| 09/25/2002 | EP1242593A2 A functional gene array in yeast |
| 09/25/2002 | EP1242592A2 A molecular switch for regulating mammalian gene expression |
| 09/25/2002 | EP1242590A2 Human lyases and associated proteins |
| 09/25/2002 | EP1242586A1 Rna polymerases from bacteriophage phi 6-phi 14 and use thereof |
| 09/25/2002 | EP1242584A2 Human kinases |
| 09/25/2002 | EP1242583A2 Human oxidoreductase proteins |
| 09/25/2002 | EP1242578A1 Cell culture medim containing growth factors and l-glutamine |
| 09/25/2002 | EP1242458A2 Brain specific binding members |
| 09/25/2002 | EP1242456A2 Scfv antibodies against disease associated molecules |
| 09/25/2002 | EP1242453A1 Dna encoding snorf62 and snorf72 receptors |
| 09/25/2002 | EP1242449A1 Modified adenovirus fibre and uses |
| 09/25/2002 | EP1242448A2 Endogenous and non-endogenous versions of human g protein-coupled receptors |
| 09/25/2002 | EP1242446A1 Immunoenzymatic quantification method |
| 09/25/2002 | EP1052909B1 Flavouring materials |
| 09/25/2002 | EP0871503B1 Inhibiting the growth of bacteria in absorbent articles by adding other bacteria |
| 09/25/2002 | EP0804591B1 Serum paraoxonase |
| 09/25/2002 | CN1371425A Plant gene expression controlled by constitutive plant V-ATPASE promoters |
| 09/25/2002 | CN1371423A Gene coding cyclic lipopeptide acrylase and expression of the same |
| 09/25/2002 | CN1371421A Tankyrase 2 materials and methods |
| 09/25/2002 | CN1371420A Orynebacterium glutamicum genes encoding phosphoenolpyruvate sugar phosphotransferase system proteins |
| 09/25/2002 | CN1371418A Genes from corynebacterium glutamicum for the biosynthesis of folic acid and their use for the microbia production of folic acid |
| 09/25/2002 | CN1371415A Fabrication of beta-pleated sheet proteins with specific binding properties |
| 09/25/2002 | CN1371390A Human G-protein coupled receptor |
| 09/25/2002 | CN1371389A 疫苗 Vaccine |
| 09/25/2002 | CN1370830A Hay bacillus and hay bacillus fermentation process of producing D-ribose |
| 09/25/2002 | CN1370829A Bacterial spawn for treating domestic organic garbage |
| 09/25/2002 | CN1370828A Intermediate thermophilic acidophilic thiobacillu strin and its application |
| 09/25/2002 | CN1370827A Artificial culture of cordycepic stroma |
| 09/25/2002 | CN1370636A Organic matter treater |
| 09/24/2002 | WO2002077203A1 Selection media for beauveriolide i or beauveriolide iii and process for selectively producing these substances |
| 09/24/2002 | US6455694 Antibiotics RK-1061 and process for preparing the same |
| 09/24/2002 | US6455686 Dermatophagoides nucleic acid molecules, proteins and uses thereof |
| 09/24/2002 | US6455683 Nucleotidesequences coding protein for use in the prevetion and treatment of infectious, inflammatory and allergic diseases |
| 09/24/2002 | US6455676 Hemoglobin mutants with increased soluble expression and/or reduced nitric oxide scavenging |
| 09/24/2002 | US6455675 GA 20-oxidase gene sequences |
| 09/24/2002 | US6455673 Polypeptide for use as vaccine in prevention of microorganismal infections |
| 09/24/2002 | US6455672 Nucleotide sequences which code protein associated with cell proliferation; for use in evaluating root and stem propagation in plants |
| 09/24/2002 | US6455504 Pesticidal macrolides |
| 09/24/2002 | US6455323 Contacting virulence protein with chemical compound, then identifying compounds which bind or interacts with protein; for bactericides against staphylococcus aureus |
| 09/24/2002 | US6455305 Nucleotide sequence of gene involved in cancer; anticarcinogenic agents |
| 09/24/2002 | US6455291 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 09/24/2002 | US6455290 Tankyrase homolog protein (THP), nucleic acids, and methods related to the same |
| 09/24/2002 | US6455287 Mechanical disruption of bacterial cells for plasmid recovery |
| 09/24/2002 | US6455284 Escherichia coli cell transformed with polynucleotide which codes for pyruvate carboxylase; for increased production of succinate and threonine |
| 09/24/2002 | US6455283 Amino acid sequence of polypeptide; for recombinant cell culture production of this growth factor; anticarcinogenic agents; wound healing agents |
| 09/24/2002 | US6455279 Culturing prokaryotic cells transformed with expression vector encoding the polypeptide with a signal sequence and expression vector encoding chaperone protein found in prokaryotes, then cleaving off the signal sequence |
| 09/24/2002 | US6455278 Nucleic acid which encodes protein of defined amino acid sequence involved in pain perception; analgesics |
| 09/24/2002 | US6455277 Polynucleotides encoding human glial cell line-derived neurotrophic factor receptor polypeptides |
| 09/24/2002 | US6455267 Methods and kits useful for determining the status of and detecting pancreatic B-cell associated autoimmune diseases |
| 09/24/2002 | US6455257 Designer diseases |
| 09/24/2002 | US6455044 5c8 antigen |
| 09/24/2002 | CA2404420A1 Selective medium for beauveriolide i substance or beauveriolide iii substance and selective production thereof |
| 09/24/2002 | CA1341388C Hybrid pesticidal toxins |
| 09/23/2002 | CA2378494A1 Catalytic domains of the human hepatocyte growth factor receptor tyrosine kinase, and materials and methods for identification of inhibitors thereof |
| 09/19/2002 | WO2002073154A2 Method and the detection of bacteria and bacterial groups |
| 09/19/2002 | WO2002072856A2 Improved process for converting nitriles to carboxylic acids using nitrilase |
| 09/19/2002 | WO2002072855A2 Process for the preparation of d-pantothenic acid and/or salts thereof |
| 09/19/2002 | WO2002072854A2 Process for the preparation of d-pantothenic acid and/or salts thereof |
| 09/19/2002 | WO2002072848A2 Increase in the vitamin e content in organisms due to an increase in the tyrosine aminotransferase activity |
| 09/19/2002 | WO2002072846A2 Synthetic genes and bacterial plasmids devoid of cpg |
| 09/19/2002 | WO2002072845A2 Salmonella promoter for heterologous gene expression |
| 09/19/2002 | WO2002072843A1 Novel vectors for animal cells and utilization thereof |
| 09/19/2002 | WO2002072841A1 Dna encoding hydantoinase, dna encoding n-carbamyl-l-amino acid hydrolase, recombinant dna, transformed cells, process for producing protein and process for producing optically active amino acid |
| 09/19/2002 | WO2002072840A2 Process for the fermentative production of d-pantothenic acid |
| 09/19/2002 | WO2002072839A1 Glucose dehydrogenase |
| 09/19/2002 | WO2002072838A2 A process for the fermentative preparation of d-pantothenic acid and/or its salts |
| 09/19/2002 | WO2002072832A2 Therapeutic binding molecules |
| 09/19/2002 | WO2002072830A2 Proteins associated with cell growth, differentiation, and death |
| 09/19/2002 | WO2002072827A1 Traf3-binding b cell-specific receptor |
| 09/19/2002 | WO2002072826A2 Neurotrophic factors |
| 09/19/2002 | WO2002072824A2 Human transient receptor potential channel protein. |